These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 29301941)
21. Extra-Adrenal Glucocorticoid Synthesis in the Intestinal Mucosa: Between Immune Homeostasis and Immune Escape. Ahmed A; Schmidt C; Brunner T Front Immunol; 2019; 10():1438. PubMed ID: 31316505 [TBL] [Abstract][Full Text] [Related]
22. Ectopic microRNA-150-5p transcription sensitizes glucocorticoid therapy response in MM1S multiple myeloma cells but fails to overcome hormone therapy resistance in MM1R cells. Palagani A; Op de Beeck K; Naulaerts S; Diddens J; Sekhar Chirumamilla C; Van Camp G; Laukens K; Heyninck K; Gerlo S; Mestdagh P; Vandesompele J; Berghe WV PLoS One; 2014; 9(12):e113842. PubMed ID: 25474406 [TBL] [Abstract][Full Text] [Related]
23. Glucocorticoids impair bone formation of bone marrow stromal stem cells by reciprocally regulating microRNA-34a-5p. Kang H; Chen H; Huang P; Qi J; Qian N; Deng L; Guo L Osteoporos Int; 2016 Apr; 27(4):1493-1505. PubMed ID: 26556739 [TBL] [Abstract][Full Text] [Related]
24. Pharmacotranscriptomic Biomarkers in Glucocorticoid Treatment of Pediatric Inflammatory Bowel Disease. Lucafò M; Stankovic B; Kotur N; Di Silvestre A; Martelossi S; Ventura A; Zukic B; Pavlovic S; Decorti G Curr Med Chem; 2018; 25(24):2855-2871. PubMed ID: 28933291 [TBL] [Abstract][Full Text] [Related]
25. The glucocorticoid receptor agonistic modulators CpdX and CpdX-D3 do not generate the debilitating effects of synthetic glucocorticoids. Hua G; Zein N; Paulen L; Chambon P Proc Natl Acad Sci U S A; 2019 Jul; 116(28):14200-14209. PubMed ID: 31221758 [TBL] [Abstract][Full Text] [Related]
26. Non-genomic Effects of Glucocorticoids: An Updated View. Panettieri RA; Schaafsma D; Amrani Y; Koziol-White C; Ostrom R; Tliba O Trends Pharmacol Sci; 2019 Jan; 40(1):38-49. PubMed ID: 30497693 [TBL] [Abstract][Full Text] [Related]
27. MicroRNAs as tools to predict glucocorticoid response in inflammatory bowel diseases. De Iudicibus S; Lucafò M; Martelossi S; Pierobon C; Ventura A; Decorti G World J Gastroenterol; 2013 Nov; 19(44):7947-54. PubMed ID: 24307788 [TBL] [Abstract][Full Text] [Related]
28. Heterogeneity in mechanisms influencing glucocorticoid sensitivity: the need for a systems biology approach to treatment of glucocorticoid-resistant inflammation. Keenan CR; Radojicic D; Li M; Radwan A; Stewart AG Pharmacol Ther; 2015 Jun; 150():81-93. PubMed ID: 25596317 [TBL] [Abstract][Full Text] [Related]
30. Expression of selected angiogenesis-related small microRNAs in patients with abnormally increased secretion of glucocorticoids. Kawa MP; Sobuś A; Litwińska Z; Osowicz-Korolonek L; Cymbaluk-Płoska A; Stecewicz I; Zagrodnik E; Romanowska H; Walczak M; Syrenicz A; Machaliński B Endokrynol Pol; 2019; 70(6):489-495. PubMed ID: 31909455 [TBL] [Abstract][Full Text] [Related]
31. New insights into the anti-inflammatory mechanisms of glucocorticoids: an emerging role for glucocorticoid-receptor-mediated transactivation. Vandevyver S; Dejager L; Tuckermann J; Libert C Endocrinology; 2013 Mar; 154(3):993-1007. PubMed ID: 23384835 [TBL] [Abstract][Full Text] [Related]
32. There goes the neighborhood: Assembly of transcriptional complexes during the regulation of metabolism and inflammation by the glucocorticoid receptor. Greulich F; Hemmer MC; Rollins DA; Rogatsky I; Uhlenhaut NH Steroids; 2016 Oct; 114():7-15. PubMed ID: 27192428 [TBL] [Abstract][Full Text] [Related]
33. Postnatal triglyceride accumulation is regulated by mineralocorticoid receptor activation under basal and stress conditions. Faught E; Vijayan MM J Physiol; 2019 Oct; 597(19):4927-4941. PubMed ID: 31246274 [TBL] [Abstract][Full Text] [Related]
34. Corticosteroid resistance in sepsis is influenced by microRNA-124--induced downregulation of glucocorticoid receptor-α. Ledderose C; Möhnle P; Limbeck E; Schütz S; Weis F; Rink J; Briegel J; Kreth S Crit Care Med; 2012 Oct; 40(10):2745-53. PubMed ID: 22846781 [TBL] [Abstract][Full Text] [Related]
35. Glucocorticoids potentiate the inhibitory capacity of programmed cell death 1 by up-regulating its expression on T cells. Maeda N; Maruhashi T; Sugiura D; Shimizu K; Okazaki IM; Okazaki T J Biol Chem; 2019 Dec; 294(52):19896-19906. PubMed ID: 31723031 [TBL] [Abstract][Full Text] [Related]
36. Boswellic acids and their derivatives as potent regulators of glucocorticoid receptor actions. Karra AG; Tziortziou M; Kylindri P; Georgatza D; Gorgogietas VA; Makiou A; Krokida A; Tsialtas I; Kalousi FD; Papadopoulos GE; Papadopoulou KΚ; Psarra AG Arch Biochem Biophys; 2020 Nov; 695():108656. PubMed ID: 33127380 [TBL] [Abstract][Full Text] [Related]
38. MicroRNAs 29b and 181a down-regulate the expression of the norepinephrine transporter and glucocorticoid receptors in PC12 cells. Deng M; Tufan T; Raza MU; Jones TC; Zhu MY J Neurochem; 2016 Oct; 139(2):197-207. PubMed ID: 27501468 [TBL] [Abstract][Full Text] [Related]
39. Cdk5 Deletion Enhances the Anti-inflammatory Potential of GC-Mediated GR Activation During Inflammation. Pfänder P; Fidan M; Burret U; Lipinski L; Vettorazzi S Front Immunol; 2019; 10():1554. PubMed ID: 31354714 [TBL] [Abstract][Full Text] [Related]
40. The pituitary function of androgen receptor constitutes a glucocorticoid production circuit. Miyamoto J; Matsumoto T; Shiina H; Inoue K; Takada I; Ito S; Itoh J; Minematsu T; Sato T; Yanase T; Nawata H; Osamura YR; Kato S Mol Cell Biol; 2007 Jul; 27(13):4807-14. PubMed ID: 17470551 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]